Acute Myeloid Leukemia: Focus on Novel Therapeutic Strategies

Acute Myeloid Leukemia: Focus on Novel Therapeutic Strategies

Show other versions (1)

Bibliographic Details
Main Authors:	Tara L. Lin, M. Yair Levy
Format:	Article
Language:	English
Published:	SAGE Publishing 2012-05-01
Series:	Clinical Medicine Insights: Oncology
Online Access:	http://la-press.com/acute-myeloid-leukemia-focus-on-novel-therapeutic-strategies-a3183

Similar Items

Acute Myeloid Leukemia: Focus on novel Therapeutic Strategies
by: Tara L. Lin, et al.
Published: (2012-01-01)

Novel therapeutic options in Acute Myeloid Leukemia
by: Michael Medinger, et al.
Published: (2016-01-01)

Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Acute Myeloid Leukemia
by: Skrtic, Marko
Published: (2012)

Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Acute Myeloid Leukemia
by: Skrtic, Marko
Published: (2012)

Deciphering the Therapeutic Resistance in Acute Myeloid Leukemia
by: Carmelo Gurnari, et al.
Published: (2020-11-01)

Acute Myeloid Leukemia Mutations: Therapeutic Implications
by: Cristina Papayannidis, et al.
Published: (2019-06-01)

Novel Biological Insights and Therapeutic Approaches in High-Risk Acute Myeloid Leukemia
by: Alachkar, Houda
Published: (2012)

Novel Agents for Acute Myeloid Leukemia
by: Mario Luppi, et al.
Published: (2018-11-01)

Therapeutic strategy in acute myeloid leukemia – the experience of a single Portuguese institution
by: Ana Espirito Santo, et al.
Published: (2014-08-01)

Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
by: Bettina Wingelhofer, et al.
Published: (2019-09-01)

Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia
by: Sarah K Tasian, et al.
Published: (2014-03-01)

Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin
by: Michele Gottardi, et al.
Published: (2021-09-01)

Therapeutic Effects of Myeloid Cell Leukemia-1 siRNA on Human Acute Myeloid Leukemia Cells
by: Hadi Karami, et al.
Published: (2014-05-01)

Characterization of novel therapeutic targets in chronic myeloid leukemia
by: Rothe, Katharina
Published: (2016)

Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia
by: Nicolas Chapuis, et al.
Published: (2019-05-01)

Therapeutic strategy for chronic myeloid leukemia: possibilities and prospects
by: A G Turkina, et al.
Published: (2013-07-01)

The changing face of acute myeloid leukemia therapeutics in the elderly population
by: Naval Daver, et al.
Published: (2015-01-01)

Pharmacologic Targeting of Chromatin Modulators As Therapeutics of Acute Myeloid Leukemia
by: Rui Lu, et al.
Published: (2017-10-01)

Identification and Characterization of New Therapeutic Targets in Acute Myeloid Leukemia
by: Benajiba, Lina
Published: (2018)

Identification and characterization of novel therapeutic targets and biomarkers in chronic myeloid leukemia
by: Lin, Hanyang
Published: (2016)

Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia
by: Marisa J. L. Aitken, et al.
Published: (2021-09-01)

Plasma Exosomes as Markers of Therapeutic Response in Patients with Acute Myeloid Leukemia
by: Chang-Sook eHong, et al.
Published: (2014-04-01)

Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia
by: Bai‐Liang He, et al.
Published: (2020-04-01)

Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia
by: Bai‐Liang He, et al.
Published: (2020-08-01)

Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia
by: Chen Hu, et al.
Published: (2021-09-01)

Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
by: Xi Jiang, et al.
Published: (2017-12-01)

Biomarkers in Acute Myeloid Leukemia: Leveraging Next Generation Sequencing Data for Optimal Therapeutic Strategies
by: Hanadi El Achi, et al.
Published: (2021-09-01)

HDAC8: A Promising Therapeutic Target for Acute Myeloid Leukemia
by: Marco Spreafico, et al.
Published: (2020-09-01)

Molecular genetic studies on Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia - with focus on prognostic markers
by: Willander, Kerstin
Published: (2014)

Angiogenesis in Acute Myeloid Leukemia and Opportunities for Novel Therapies
by: Angelica Trujillo, et al.
Published: (2012-01-01)

Therapeutic reactivation of protein phosphatase 2A in acute myeloid leukemia
by: Kavitha eRamaswamy, et al.
Published: (2015-02-01)

From Bench to Bedside and Beyond: Therapeutic Scenario in Acute Myeloid Leukemia
by: Carmelo Gurnari, et al.
Published: (2020-02-01)

Epigenetic Regulators in the Development, Maintenance, and Therapeutic Targeting of Acute Myeloid Leukemia
by: Younguk Sun, et al.
Published: (2018-02-01)

Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs
by: Armin Zebisch, et al.
Published: (2016-12-01)

The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML)
by: Katherine L. B. Borden, et al.
Published: (2012-11-01)

Advances in the drug therapies of acute myeloid leukemia (except acute promyelocytic leukemia)
by: Lin M, et al.
Published: (2018-04-01)

Circular RNAs in Hematopoiesis with a Focus on Acute Myeloid Leukemia and Myelodysplastic Syndrome
by: Michaela Dostalova Merkerova, et al.
Published: (2020-08-01)

Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity
by: Adam J. Lamble, et al.
Published: (2018-06-01)

Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway
by: Antonella Padella, et al.
Published: (2021-01-01)

Acute Myeloid Leukemia: Is It T Time?
by: Meriem Ben Khoud, et al.
Published: (2021-05-01)